Journal of Applied Biological Chemistry

The Korean Society for Applied Biological Chemistry (한국응용생명화학회)
권호 표지

Allogeneic Transplantation of Mesenchymal Stem Cells from Human Umbilical Cord Blood

  • Lee, Jae-Kwon (Department of Science Education (Biology), College of Education, Chungbuk National University)
  • Published : 2007.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

The cord blood serves as a vehicle for the transportation of oxygen and nutrients to the fetus. In the past, the human cord blood has generally been discarded after birth. However, numerous studies have described the regenerative ability of the cord blood cells in various incurable diseases. The umbilical cord blood (UCB)-derived stem cells are obtained through non-invasive methods that are not harmful to both the mother and the fetus. Furthermore, the cord blood stem cells are more immature than the adult stem cells and expand readily in vitro. The mesenchymal stem cells (MSCs) have the capacity to differentiate in vitro into various mesodermal (bone, cartilage, tendon, muscle, and adipose), endodermal (hepatocyte), and ectodermal (neurons) tissues. This review describes the immunological properties of the human UCB-MSCs to assess their potential usefulness in the allogeneic transplantation for the regenerative medicine.

Keywords

References

  1. Aggarwal S and Pittenger MF (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105, 1815-1822 https://doi.org/10.1182/blood-2004-04-1559
  2. Beadling C, Johnson KW, and Smith KA (1993) Isolation of interleukin 2-induced immediate-early genes. Proc Natl Acad Sci USA 90, 2719-2723
  3. Beadling C and Smith KA (2002) DNA array analysis of interleukin-2-regulated immediate/early genes. Med Immunol 1, 2 https://doi.org/10.1186/1476-9433-1-2
  4. Bensinger WI, Buckner D, and Gahrton G (1997) Allogeneic stem cell transplantation for multiple myeloma. Hematol Oncol Clin North Am 11, 147-157 https://doi.org/10.1016/S0889-8588(05)70420-2
  5. Beyth S, Borovsky Z, Mevorach D, Liebergall M, Gazit Z, Aslan H, Galun E, and Rachmilewitz J (2005) Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105, 2214-2219 https://doi.org/10.1182/blood-2004-07-2921
  6. Bicknese AR, Goodwin HS, Quinn CO, Henderson VC, Chien SN, and Wall DA (2002) Human umbilical cord blood cells can be induced to express markers for neurons and glia. Cell Transplant 11, 261-264
  7. Bieback K, Kern S, Kluter H, and Eichler H (2004) Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 22, 625-634 https://doi.org/10.1634/stemcells.22-4-625
  8. Broxmeyer HE, Douglas GW, Hangoc G, Cooper S, Bard J, English D, Arny M, Thomas L, and Boyse EA (1989) Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA 86, 3828-3832
  9. Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, and Fisk NM (2001) Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 98, 2396-2402 https://doi.org/10.1182/blood.V98.8.2396
  10. Chang YJ, Shih DT, Tseng CP, Hsieh TB, Lee DC, and Hwang SM (2006) Disparate mesenchyme-lineage tendencies in mesenchymal stem cells from human bone marrow and umbilical cord blood. Stem Cells 24, 679- 685 https://doi.org/10.1634/stemcells.2004-0308
  11. Chen SL, Fang WW, Ye F, Liu YH, Qian J, Shan SJ, Zhang JJ, Chunhua RZ, Liao LM, Lin S, and Sun JP (2004) Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 94, 92-95 https://doi.org/10.1016/j.amjcard.2004.03.034
  12. Chopp M and Li Y (2002) Treatment of neural injury with marrow stromal cells. Lancet Neurol 1, 92-100 https://doi.org/10.1016/S1474-4422(02)00040-6
  13. Chopp M, Zhang XH, Li Y, Wang L, Chen J, Lu D, Lu M, and Rosenblum M (2000) Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation. Neuroreport 11, 3001-3005 https://doi.org/10.1097/00001756-200009110-00035
  14. Chuah MK, Van Damme A, Zwinnen H, Goovaerts I, Vanslembrouck V, Collen D, and Vandendriessche T (2000) Long-term persistence of human bone marrow stromal cells transduced with factor VIII-retroviral vectors and transient production of therapeutic levels of human factor VIII in nonmyeloablated immunodeficient mice. Hum Gene Ther 11, 729-738 https://doi.org/10.1089/10430340050015626
  15. Dai W, Hale SL, Martin BJ, Kuang JQ, Dow JS, Wold LE, and Kloner RA (2005) Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation 112, 214-223 https://doi.org/10.1161/CIRCULATIONAHA.104.527937
  16. De Bari C, Dell'Accio F, Vandenabeele F, Vermeesch JR, Raymackers JM, and Luyten FP (2003) Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. J Cell Biol 160, 909-918 https://doi.org/10.1083/jcb.200212064
  17. Devine SM, Bartholomew AM, Mahmud N, Nelson M, Patil S, Hardy W, Sturgeon C, Hewett T, Chung T, Stock W, Sher D, Weissman S, Ferrer K, Mosca J, Deans R, Moseley A, and Hoffman R (2001) Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. Exp Hematol 29, 244-255 https://doi.org/10.1016/S0301-472X(00)00635-4
  18. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, Grisanti S, and Gianni AM (2002) Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99, 3838-3843 https://doi.org/10.1182/blood.V99.10.3838
  19. Djouad F, Plence P, Bony C, Tropel P, Apparailly F, Sany J, Noel D, and Jorgensen C (2003) Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 102, 3837-3844 https://doi.org/10.1182/blood-2003-04-1193
  20. Drize NJ, Surin VL, Gan OI, Deryugina EI, and Chertkov JL (1992) Gene therapy model for stromal precursor cells of hematopoietic microenvironment. Leukemia 6 Suppl 3, 174S-175S
  21. Eckes B, Colucci-Guyon E, Smola H, Nodder S, Babinet C, Krieg T, and Martin P (2000) Impaired wound healing in embryonic and adult mice lacking vimentin. J Cell Sci 113 (Pt 13), 2455-2462
  22. Erices A, Conget P, and Minguell JJ (2000) Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 109, 235-242 https://doi.org/10.1046/j.1365-2141.2000.01986.x
  23. Gang EJ, Jeong JA, Hong SH, Hwang SH, Kim SW, Yang IH, Ahn C, Han H, and Kim H (2004) Skeletal myogenic differentiation of mesenchymal stem cells isolated from human umbilical cord blood. Stem Cells 22, 617- 624 https://doi.org/10.1634/stemcells.22-4-617
  24. Gimble JM, Robinson CE, Wu X, and Kelly KA (1996) The function of adipocytes in the bone marrow stroma: an update. Bone 19, 421-428 https://doi.org/10.1016/S8756-3282(96)00258-X
  25. Gluckman E (2000) Current status of umbilical cord blood hematopoietic stem cell transplantation. Exp Hematol 28, 1197-1205 https://doi.org/10.1016/S0301-472X(00)00540-3
  26. Goodwin HS, Bicknese AR, Chien SN, Bogucki BD, Quinn CO, and Wall DA (2001) Multilineage differentiation activity by cells isolated from umbilical cord blood: expression of bone, fat, and neural markers. Biol Blood Marrow Transplant 7, 581-588 https://doi.org/10.1053/bbmt.2001.v7.pm11760145
  27. Gotherstrom C, Ringden O, Tammik C, Zetterberg E, Westgren M, and Le Blanc K (2004) Immunologic properties of human fetal mesenchymal stem cells. Am J Obstet Gynecol 190, 239-245 https://doi.org/10.1016/j.ajog.2003.07.022
  28. Grauss RW, Winter EM, van Tuyn J, Pijnappels DA, Vicente Steijn R, Hogers B, van der Geest R, de Vries AA, Steendijk P, van der Laarse A, Gittenberger-de Groot AC, Schalij MJ, and Atsma DE (2007) Mesenchymal Stem Cells from Ischemic Heart Disease Patients Improve Left Ventricular Function after Acute Myocardial Infarction. Am J Physiol Heart Circ Physiol
  29. Grinnemo KH, Mansson-Broberg A, Leblanc K, Corbascio M, Wardell E, Siddiqui AJ, Hao X, Sylven C, and Dellgren G (2006) Human mesenchymal stem cells do not differentiate into cardiomyocytes in a cardiac ischemic xenomodel. Ann Med 38, 144-153 https://doi.org/10.1080/07853890500422982
  30. Heng BC, Haider H, Sim EK, Cao T, and Ng SC (2004) Strategies for directing the differentiation of stem cells into the cardiomyogenic lineage in vitro. Cardiovasc Res 62, 34-42 https://doi.org/10.1016/j.cardiores.2003.12.022
  31. Herrera MB, Bussolati B, Bruno S, Fonsato V, Romanazzi GM, and Camussi G (2004) Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int J Mol Med 14, 1035-1041
  32. Hutcheson KA, Atkins BZ, Hueman MT, Hopkins MB, Glower DD, and Taylor DA (2000) Comparison of benefits on myocardial performance of cellular cardiomyoplasty with skeletal myoblasts and fibroblasts. Cell Transplant 9, 359-368 https://doi.org/10.1177/096368970000900307
  33. Jang YK, Jung DH, Jung MH, Kim DH, Yoo KH, Sung KW, Koo HH, Oh W, Yang YS, and Yang SE (2006) Mesenchymal stem cells feeder layer from human umbilical cord blood for ex vivo expanded growth and proliferation of hematopoietic progenitor cells. Ann Hematol 85, 212-225 https://doi.org/10.1007/s00277-005-0047-3
  34. Jeong JA, Gang EJ, Hong SH, Hwang SH, Kim SW, Yang IH, Ahn C, Han H, and Kim H (2004) Rapid neural differentiation of human cord blood-derived mesenchymal stem cells. Neuroreport 15, 1731-1734 https://doi.org/10.1097/01.wnr.0000134846.79002.5c
  35. Kang KS, Kim SW, Oh YH, Yu JW, Kim KY, Park HK, Song CH, and Han H (2005) A 37-year-old spinal cordinjured female patient, transplanted of multipotent stem cells from human UC blood, with improved sensory perception and mobility, both functionally and morphologically: a case study. Cytotherapy 7, 368-373 https://doi.org/10.1080/14653240500238160
  36. Kato S, Nishihira H, Hara H, Kato K, Takahashi T, Sato N, Kodera Y, Saito H, Sato H, and Takanashi M (2000) Cord blood transplantation and cord blood bank in Japan. Bone Marrow Transplant 25 Suppl 2, S68-70 https://doi.org/10.1038/sj.bmt.1702358
  37. Kern S, Eichler H, Stoeve J, Kluter H, and Bieback K (2006) Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24, 1294-1301 https://doi.org/10.1634/stemcells.2005-0342
  38. Kim SW, Han H, Chae GT, Lee SH, Bo S, Yoon JH, Lee YS, Lee KS, Park HK, and Kang KS (2006) Successful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buerger's disease and ischemic limb disease animal model. Stem Cells 24, 1620-1626 https://doi.org/10.1634/stemcells.2005-0365
  39. Kinner B, Gerstenfeld LC, Einhorn TA, and Spector M (2002a) Expression of smooth muscle actin in connective tissue cells participating in fracture healing in a murine model. Bone 30, 738-745 https://doi.org/10.1016/S8756-3282(02)00695-6
  40. Kinner B, Zaleskas JM, and Spector M (2002b) Regulation of smooth muscle actin expression and contraction in adult human mesenchymal stem cells. Exp Cell Res 278, 72-83 https://doi.org/10.1006/excr.2002.5561
  41. Klyushnenkova E, Mosca JD, Zernetkina V, Majumdar MK, Beggs KJ, Simonetti DW, Deans RJ, and McIntosh KR (2005) T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. J Biomed Sci 12, 47-57 https://doi.org/10.1007/s11373-004-8183-7
  42. Laughlin MJ (2001) Umbilical cord blood for allogeneic transplantation in children and adults. Bone Marrow Transplant 27, 1-6 https://doi.org/10.1038/sj.bmt.1702740
  43. Laughlin MJ, Barker J, Bambach B, Koc ON, Rizzieri DA, Wagner JE, Gerson SL, Lazarus HM, Cairo M, Stevens CE, Rubinstein P, and Kurtzberg J (2001) Hematopoietic engraftment and survival in adult recipients of umbilical- cord blood from unrelated donors. N Engl J Med 344, 1815-1822 https://doi.org/10.1056/NEJM200106143442402
  44. Lee CI, Kohn DB, Ekert JE, and Tarantal AF (2004a) Morphological analysis and lentiviral transduction of fetal monkey bone marrow-derived mesenchymal stem cells. Mol Ther 9, 112-123
  45. Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, and Chen TH (2004b) Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 103, 1669- 1675 https://doi.org/10.1182/blood-2003-05-1670
  46. Liechty KW, MacKenzie TC, Shaaban AF, Radu A, Moseley AM, Deans R, Marshak DR, and Flake AW (2000) Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 6, 1282-1286 https://doi.org/10.1038/81395
  47. Liu CH and Hwang SM (2005) Cytokine interactions in mesenchymal stem cells from cord blood. Cytokine 32, 270-279 https://doi.org/10.1016/j.cyto.2005.11.003
  48. Lu FZ, Fujino M, Kitazawa Y, Uyama T, Hara Y, Funeshima N, Jiang JY, Umezawa A, and Li XK (2005) Characterization and gene transfer in mesenchymal stem cells derived from human umbilical-cord blood. J Lab Clin Med 146, 271-278 https://doi.org/10.1016/j.lab.2005.07.003
  49. Lu P, Blesch A, and Tuszynski MH (2004) Induction of bone marrow stromal cells to neurons: differentiation, transdifferentiation, or artifact? J Neurosci Res 77, 174- 191 https://doi.org/10.1002/jnr.20148
  50. Mackenzie TC and Flake AW (2001) Human mesenchymal stem cells persist, demonstrate site-specific multipotential differentiation, and are present in sites of wound healing and tissue regeneration after transplantation into fetal sheep. Blood Cells Mol Dis 27, 601-604 https://doi.org/10.1006/bcmd.2001.0424
  51. Mangeot PE, Duperrier K, Negre D, Boson B, Rigal D, Cosset FL, and Darlix JL (2002) High levels of transduction of human dendritic cells with optimized SIV vectors. Mol Ther 5, 283-290 https://doi.org/10.1006/mthe.2002.0541
  52. Millington-Ward S, Allers C, Tuohy G, Conget P, Allen D, McMahon HP, Kenna PF, Humphries P, and Farrar GJ (2002) Validation in mesenchymal progenitor cells of a mutation-independent ex vivo approach to gene therapy for osteogenesis imperfecta. Hum Mol Genet 11, 2201- 2206 https://doi.org/10.1093/hmg/11.19.2201
  53. Mueller SM and Glowacki J (2001) Age-related decline in the osteogenic potential of human bone marrow cells cultured in three-dimensional collagen sponges. J Cell Biochem 82, 583-590 https://doi.org/10.1002/jcb.1174
  54. Newcomb JD, Ajmo CT, Jr., Sanberg CD, Sanberg PR, Pennypacker KR, and Willing AE (2006) Timing of cord blood treatment after experimental stroke determines therapeutic efficacy. Cell Transplant 15, 213-223 https://doi.org/10.3727/000000006783982043
  55. Nishiyama N, Miyoshi S, Hida N, Uyama T, Okamoto K, Ikegami Y, Miyado K, Segawa K, Terai M, Sakamoto M, Ogawa S, and Umezawa A (2007) The significant cardiomyogenic potential of human umbilical cord blood-derived mesenchymal stem cells in vitro. Stem Cells 25, 2017-2024 https://doi.org/10.1634/stemcells.2006-0662
  56. Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N, and Phinney DG (2003) Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA 100, 8407-8411
  57. Ourednik J, Ourednik V, Lynch WP, Schachner M, and Snyder EY (2002) Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons. Nat Biotechnol 20, 1103-1110 https://doi.org/10.1038/nbt750
  58. Potian JA, Aviv H, Ponzio NM, Harrison JS, and Rameshwar P (2003) Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. J Immunol 171, 3426-3434 https://doi.org/10.4049/jimmunol.171.7.3426
  59. Puissant B, Barreau C, Bourin P, Clavel C, Corre J, Bousquet C, Taureau C, Cousin B, Abbal M, Laharrague P, Penicaud L, Casteilla L, and Blancher A (2005) Immunomodulatory effect of human adipose tissuederived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol 129, 118-129 https://doi.org/10.1111/j.1365-2141.2005.05409.x
  60. Rasmusson I, Ringden O, Sundberg B, and Le Blanc K (2003) Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 76, 1208-1213 https://doi.org/10.1097/01.TP.0000082540.43730.80
  61. Robb RJ and Smith KA (1981) Heterogeneity of human Tcell growth factor(s) due to variable glycosylation. Mol Immunol 18, 1087-1094 https://doi.org/10.1016/0161-5890(81)90024-9
  62. Rosada C, Justesen J, Melsvik D, Ebbesen P, and Kassem M (2003) The human umbilical cord blood: a potential source for osteoblast progenitor cells. Calcif Tissue Int 72, 135-142 https://doi.org/10.1007/s00223-002-2002-9
  63. Rubinstein P, Carrier C, Scaradavou A, Kurtzberg J, Adamson J, Migliaccio AR, Berkowitz RL, Cabbad M, Dobrila NL, Taylor PE, Rosenfield RE, and Stevens CE (1998) Outcomes among 562 recipients of placentalblood transplants from unrelated donors. N Engl J Med 339, 1565-1577 https://doi.org/10.1056/NEJM199811263392201
  64. Shake JG, Gruber PJ, Baumgartner WA, Senechal G, Meyers J, Redmond JM, Pittenger MF, and Martin BJ (2002) Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg 73, 1919-1925; discussion 1926 https://doi.org/10.1016/S0003-4975(02)03517-8
  65. Silva GV, Litovsky S, Assad JA, Sousa AL, Martin BJ, Vela D, Coulter SC, Lin J, Ober J, Vaughn WK, Branco RV, Oliveira EM, He R, Geng YJ, Willerson JT, and Perin EC (2005) Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 111, 150-156 https://doi.org/10.1161/01.CIR.0000151812.86142.45
  66. Skalli O, Pelte MF, Peclet MC, Gabbiani G, Gugliotta P, Bussolati G, Ravazzola M, and Orci L (1989) Alphasmooth muscle actin, a differentiation marker of smooth muscle cells, is present in microfilamentous bundles of pericytes. J Histochem Cytochem 37, 315-321 https://doi.org/10.1177/37.3.2918221
  67. Stern JB and Smith KA (1986) Interleukin-2 induction of Tcell G1 progression and c-myb expression. Science 233, 203-206 https://doi.org/10.1126/science.3523754
  68. Studer L, Tabar V, and McKay RD (1998) Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats. Nat Neurosci 1, 290-295 https://doi.org/10.1038/1105
  69. Swanger SA, Neuhuber B, Himes BT, Bakshi A, and Fischer I (2005) Analysis of allogeneic and syngeneic bone marrow stromal cell graft survival in the spinal cord. Cell Transplant 14, 775-786 https://doi.org/10.3727/000000005783982594
  70. Takaoka A and Yanai H (2006) Interferon signalling network in innate defence. Cell Microbiol 8, 907-922 https://doi.org/10.1111/j.1462-5822.2006.00716.x
  71. Toma C, Pittenger MF, Cahill KS, Byrne BJ, and Kessler PD (2002) Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105, 93-98 https://doi.org/10.1161/hc0102.101442
  72. Will AM (1999) Umbilical cord blood transplantation. Arch Dis Child 80, 3-6 https://doi.org/10.1136/adc.80.1.3
  73. Yang SE, Ha CW, Jung M, Jin HJ, Lee M, Song H, Choi S, Oh W, and Yang YS (2004) Mesenchymal stem/progenitor cells developed in cultures from UC blood. Cytotherapy 6, 476-486 https://doi.org/10.1080/14653240410005041